img

Global Biliary Tumor Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biliary Tumor Market Research Report 2024

Biliary Tumor is a form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile – a fluid that helps digest fats – to the small intestine.
According to Mr Accuracy reports’s new survey, global Biliary Tumor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biliary Tumor market research.
Key companies engaged in the Biliary Tumor industry include NuCana, NeoGenomics, Novartis, GlaxoSmithKline and Southwest Oncology Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Biliary Tumor were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biliary Tumor market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biliary Tumor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
Segment by Type
Mecine
Surgery
Other

Segment by Application


Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biliary Tumor report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Tumor Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Mecine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biliary Tumor Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biliary Tumor Market Perspective (2024-2034)
2.2 Biliary Tumor Growth Trends by Region
2.2.1 Global Biliary Tumor Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Biliary Tumor Historic Market Size by Region (2024-2024)
2.2.3 Biliary Tumor Forecasted Market Size by Region (2024-2034)
2.3 Biliary Tumor Market Dynamics
2.3.1 Biliary Tumor Industry Trends
2.3.2 Biliary Tumor Market Drivers
2.3.3 Biliary Tumor Market Challenges
2.3.4 Biliary Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biliary Tumor Players by Revenue
3.1.1 Global Top Biliary Tumor Players by Revenue (2024-2024)
3.1.2 Global Biliary Tumor Revenue Market Share by Players (2024-2024)
3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biliary Tumor Revenue
3.4 Global Biliary Tumor Market Concentration Ratio
3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2022
3.5 Biliary Tumor Key Players Head office and Area Served
3.6 Key Players Biliary Tumor Product Solution and Service
3.7 Date of Enter into Biliary Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biliary Tumor Breakdown Data by Type
4.1 Global Biliary Tumor Historic Market Size by Type (2024-2024)
4.2 Global Biliary Tumor Forecasted Market Size by Type (2024-2034)
5 Biliary Tumor Breakdown Data by Application
5.1 Global Biliary Tumor Historic Market Size by Application (2024-2024)
5.2 Global Biliary Tumor Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Biliary Tumor Market Size (2024-2034)
6.2 North America Biliary Tumor Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Biliary Tumor Market Size by Country (2024-2024)
6.4 North America Biliary Tumor Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biliary Tumor Market Size (2024-2034)
7.2 Europe Biliary Tumor Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Biliary Tumor Market Size by Country (2024-2024)
7.4 Europe Biliary Tumor Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biliary Tumor Market Size (2024-2034)
8.2 Asia-Pacific Biliary Tumor Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Biliary Tumor Market Size by Region (2024-2024)
8.4 Asia-Pacific Biliary Tumor Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biliary Tumor Market Size (2024-2034)
9.2 Latin America Biliary Tumor Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Biliary Tumor Market Size by Country (2024-2024)
9.4 Latin America Biliary Tumor Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biliary Tumor Market Size (2024-2034)
10.2 Middle East & Africa Biliary Tumor Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Biliary Tumor Market Size by Country (2024-2024)
10.4 Middle East & Africa Biliary Tumor Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuCana
11.1.1 NuCana Company Detail
11.1.2 NuCana Business Overview
11.1.3 NuCana Biliary Tumor Introduction
11.1.4 NuCana Revenue in Biliary Tumor Business (2024-2024)
11.1.5 NuCana Recent Development
11.2 NeoGenomics
11.2.1 NeoGenomics Company Detail
11.2.2 NeoGenomics Business Overview
11.2.3 NeoGenomics Biliary Tumor Introduction
11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2024-2024)
11.2.5 NeoGenomics Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Biliary Tumor Introduction
11.3.4 Novartis Revenue in Biliary Tumor Business (2024-2024)
11.3.5 Novartis Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Biliary Tumor Introduction
11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2024-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Southwest Oncology Group
11.5.1 Southwest Oncology Group Company Detail
11.5.2 Southwest Oncology Group Business Overview
11.5.3 Southwest Oncology Group Biliary Tumor Introduction
11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2024-2024)
11.5.5 Southwest Oncology Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Mecine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Biliary Tumor Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Biliary Tumor Market Size by Region (2024-2024) & (US$ Million)
Table 8. Global Biliary Tumor Market Share by Region (2024-2024)
Table 9. Global Biliary Tumor Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Biliary Tumor Market Share by Region (2024-2034)
Table 11. Biliary Tumor Market Trends
Table 12. Biliary Tumor Market Drivers
Table 13. Biliary Tumor Market Challenges
Table 14. Biliary Tumor Market Restraints
Table 15. Global Biliary Tumor Revenue by Players (2024-2024) & (US$ Million)
Table 16. Global Biliary Tumor Market Share by Players (2024-2024)
Table 17. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2022)
Table 18. Ranking of Global Top Biliary Tumor Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2024-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biliary Tumor Product Solution and Service
Table 22. Date of Enter into Biliary Tumor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biliary Tumor Market Size by Type (2024-2024) & (US$ Million)
Table 25. Global Biliary Tumor Revenue Market Share by Type (2024-2024)
Table 26. Global Biliary Tumor Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Biliary Tumor Revenue Market Share by Type (2024-2034)
Table 28. Global Biliary Tumor Market Size by Application (2024-2024) & (US$ Million)
Table 29. Global Biliary Tumor Revenue Market Share by Application (2024-2024)
Table 30. Global Biliary Tumor Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Biliary Tumor Revenue Market Share by Application (2024-2034)
Table 32. North America Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. North America Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 34. North America Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. Europe Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 37. Europe Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Biliary Tumor Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Asia-Pacific Biliary Tumor Market Size by Region (2024-2024) & (US$ Million)
Table 40. Asia-Pacific Biliary Tumor Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 42. Latin America Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 43. Latin America Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Biliary Tumor Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Middle East & Africa Biliary Tumor Market Size by Country (2024-2024) & (US$ Million)
Table 46. Middle East & Africa Biliary Tumor Market Size by Country (2024-2034) & (US$ Million)
Table 47. NuCana Company Detail
Table 48. NuCana Business Overview
Table 49. NuCana Biliary Tumor Product
Table 50. NuCana Revenue in Biliary Tumor Business (2024-2024) & (US$ Million)
Table 51. NuCana Recent Development
Table 52. NeoGenomics Company Detail
Table 53. NeoGenomics Business Overview
Table 54. NeoGenomics Biliary Tumor Product
Table 55. NeoGenomics Revenue in Biliary Tumor Business (2024-2024) & (US$ Million)
Table 56. NeoGenomics Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Biliary Tumor Product
Table 60. Novartis Revenue in Biliary Tumor Business (2024-2024) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. GlaxoSmithKline Company Detail
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Biliary Tumor Product
Table 65. GlaxoSmithKline Revenue in Biliary Tumor Business (2024-2024) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Southwest Oncology Group Company Detail
Table 68. Southwest Oncology Group Business Overview
Table 69. Southwest Oncology Group Biliary Tumor Product
Table 70. Southwest Oncology Group Revenue in Biliary Tumor Business (2024-2024) & (US$ Million)
Table 71. Southwest Oncology Group Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tumor Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Biliary Tumor Market Share by Type: 2022 VS 2034
Figure 3. Mecine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Biliary Tumor Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Biliary Tumor Market Share by Application: 2022 VS 2034
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Biliary Tumor Report Years Considered
Figure 12. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 13. Global Biliary Tumor Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Biliary Tumor Market Share by Region: 2022 VS 2034
Figure 15. Global Biliary Tumor Market Share by Players in 2022
Figure 16. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2022
Figure 18. North America Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. North America Biliary Tumor Market Share by Country (2024-2034)
Figure 20. United States Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Canada Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Biliary Tumor Market Share by Country (2024-2034)
Figure 24. Germany Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. France Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. U.K. Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Italy Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Russia Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Nordic Countries Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Biliary Tumor Market Share by Region (2024-2034)
Figure 32. China Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Japan Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. South Korea Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Southeast Asia Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. India Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Australia Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Biliary Tumor Market Share by Country (2024-2034)
Figure 40. Mexico Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Brazil Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Biliary Tumor Market Share by Country (2024-2034)
Figure 44. Turkey Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Saudi Arabia Biliary Tumor Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. NuCana Revenue Growth Rate in Biliary Tumor Business (2024-2024)
Figure 47. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2024-2024)
Figure 48. Novartis Revenue Growth Rate in Biliary Tumor Business (2024-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2024-2024)
Figure 50. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2024-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed